Era of Immunotherapy

Abstract

Cancer immunotherapy beginning with the vision of immunological surveillance advocated by F. M. Burnet have been evolving in association with the advance of genetic engineering and genetic analysis. No one doubts the presence of cancer immunotherapy.

In this paper, I overview the cancer immunotherapy and introduce the developments of cancer immunotherapy in Japan. And this innovation is classified into the innovation by emerging knowledge stated by P. F. Drucker. The development of business strategies based by MOT is necessary for achieving this innovation.